4 Stocks With 20% Upside? Barclays PLC, Persimmon plc, CVS Group Plc & Judges Scientific PLC

Are these 4 stocks set to soar? Barclays PLC (LON: BARC), Persimmon plc (LON: PSN), CVS Group Plc (LON: CVSG) and Judges Scientific PLC (LON: JDG)

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Housebuilder Persimmon (LSE: PSN) has been one of the best performing stocks in the FTSE 350 in the last five years. Its shares have soared by 425% during that time as the UK housing market has enjoyed a purple patch brought about by low interest rates and a lack of housing supply.

Looking ahead, gains of 20%+ could easily be posted by Persimmon in the medium term, since it offers very strong growth prospects at a very appealing price. For example, its earnings are due to rise by 25% in the current year and by a further 10% next year. Both of these figures are well ahead of the wider market’s expected growth rate of mid to high-single digits but, despite this, Persimmon trades on a price to earnings (P/E) ratio of just 13.6, which indicates that a rating expansion is very realistic. Certainly, interest rate rises are on the horizon, but demand for housing should keep housebuilders performing well.

Similarly, Barclays (LSE: BARC) could easily post a rise in its share price of 20%. That’s because it trades on a price to book value (P/B) ratio of just 0.6, so even a rise in valuation of two-thirds would leave Barclays trading at its net asset value, which would still be appealing.

The catalyst to push its share price higher is likely to be a new strategy under a new CEO. This is unlikely to occur until 2016, but a new man/woman at the helm may stimulate investor interest in Barclays through focusing to a greater degree on its investment banking division, for example, or on returning a greater proportion of profit to investors in the bank as a dividend. And, with Barclays being highly profitable and due to increase its earnings at a double-digit rate over the next two years, it may not take much to convince the market that its shares should trade considerably higher than they have during 2015.

Meanwhile, today’s results from veterinary group CVS (LSE: CVSG) show that the business has huge growth potential. That’s because it has only 12% of the UK small animal vet market as well as a negligible portion of the equine and large animal vet markets. And, with the company’s strategy clearly paying off with pretax profit growth of 35% in its most recent year, CVS’s valuation is likely to move much higher.

Clearly, today’s 7.5% rise in its share price is impressive, but CVS could easily rise by another 20%. Its financial standing remains strong and its policy of making multiple acquisitions could lead to further growth alongside excellent organic performance.

On the topic of acquisitions, Judges Scientific (LSE: JDG) also released an upbeat update today. It is on-track to meet full-year expectations and, despite a weak first quarter, it expects the rest of the year to show improvement. As such, the acquirer of scientific instrument companies is currently up around 3% at the time of writing.

Looking ahead, more gains are on the cards for the company’s investors. That’s because Judges Scientific is expected to grow its bottom line by 14% next year and, with it trading on a price to earnings growth (PEG) ratio of just 0.9, it appears to offer excellent growth prospects at a very reasonable price.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Peter Stephens owns shares of Barclays, Judges Scientific, and Persimmon. The Motley Fool UK has recommended Barclays. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Bus waiting in front of the London Stock Exchange on a sunny day.
Investing Articles

If interest rate cuts are coming, I think these UK growth stocks could soar!

Falling interest could be great news for UK growth stocks, especially those that have been under the cosh recently. Paul…

Read more »

Investing Articles

Are these the best stocks to buy on the FTSE right now?

With the UK stock market on the way to hitting new highs, this Fool is considering which are the best…

Read more »

Petrochemical engineer working at night with digital tablet inside oil and gas refinery plant
Investing Articles

Can the Centrica dividend keep on growing?

Christopher Ruane considers some positive factors that might see continued growth in the Centrica dividend -- as well as some…

Read more »

Smiling family of four enjoying breakfast at sunrise while camping
Investing Articles

How I’d turn my £12,000 of savings into passive income of £1,275 a month

This Fool is considering a strategy that he believes can help him achieve a stable passive income stream with a…

Read more »

Person holding magnifying glass over important document, reading the small print
Investing Articles

2 top FTSE 250 investment trusts trading at attractive discounts!

This pair of discounted FTSE 250 trusts appear to be on sale right now. Here's why I'd scoop up their…

Read more »

Smiling young man sitting in cafe and checking messages, with his laptop in front of him.
Investing Articles

3 things that could push the Lloyds share price to 60p and beyond

The Lloyds share price has broken through 50p. Next step 60p? And then what? Here are some thoughts on what…

Read more »

Young female business analyst looking at a graph chart while working from home
Investing Articles

£1,000 in Rolls-Royce shares a year ago would be worth this much now

Rolls-Royce shares have posted one of the best stock market gains of the past 12 months. But what might the…

Read more »

Investing Articles

Are HSBC shares a FTSE bargain? Here’s what the charts say!

There are plenty of dirt-cheap FTSE 100 banking stocks for investors to choose from today. Our writer Royston Wild believes…

Read more »